BOSTON, June 12, 2019 /PRNewswire/ — In response to recent severe storms, winds, and flooding, Blue Cross Blue Shield of Massachusetts (BCBSMA), Inc. is expediting access to care for members who live in affected areas of Arkansas and Oklahoma.
Through our national Blue Card plan, we provide health care coverage for people across the country, including nearly 2,000 members in impacted parts of Arkansas and Oklahoma. In the wake of the storms, we are working to ensure that members can access health services and medications quickly and in locations convenient to them. For our members living in affected counties, effective immediately, we are:
“We want our members in these areas to know they can get the care they need when they need it,” said Andrew Dreyfus, president & CEO of Blue Cross Blue Shield of Massachusetts. “Our hope is that this will make it easier for them to access services and medications even if they’re displaced while dealing with the aftermath of these severe storms.”
About Blue Cross Blue Shield of Massachusetts
Blue Cross Blue Shield of Massachusetts (bluecrossma.com) is a community-focused, tax-paying, not-for-profit health plan headquartered in Boston. We are committed to the relentless pursuit of quality, affordable health care with an unparalleled consumer experience. Consistent with our promise to always put our members first, we are rated among the nation’s best health plans for member satisfaction and quality. Connect with us on Facebook, Twitter, YouTube, and LinkedIn.
View original content to download multimedia:http://www.prnewswire.com/news-releases/blue-cross-blue-shield-of-massachusetts-expedites-access-to-care-for-members-affected-by-severe-weather-in-arkansas-and-oklahoma-300866407.html
SOURCE Blue Cross Blue Shield of Massachusetts
Company Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United…
Industry initiative URPA broadens calls to improve speed, accuracy of recall communicationWEST HOLLYWOOD, CA /…
ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual…
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
-- Advancing ongoing Phase 2b CHASE trial of KPI-012 for PCED; topline data targeted by…
NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading…